Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Salbutamol → Methyl-5[[(1,1-dimethylethyl)(phenylmethyl)-amino]acetyl]-2-hydroxybenzoate
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Salbutamol | HCID 2083 | — |
| 반응물 | Acetophenone | HCID 7410 | — |
| 반응물 | N-(1,1-Dimethylethyl)benzenemethanamine | HCID 76908 | — |
| 반응물 | Bromoacetyl-2-hydroxybenzoate | HCID 21684415 | — |
| 생성물 | Methyl-5[[(1,1-dimethylethyl)(phenylmethyl)-amino]acetyl]-2-hydroxybenzoate | HCID 12814682 | — |
반응 단계
Albuterol has been prepared, see Irish Patent Specification No. 31391, Aug. 9, 1972, starting from the appropriate acetophenone derivative methyl-5-(bromoacetyl-2-hydroxybenzoate, by condensation with N-(1,1-dimethylethyl)benzenemethanamine in the presence of base to form the ketonic ester, methyl-5[[(1,1-dimethylethyl)(phenylmethyl)-amino]acetyl]-2-hydroxybenzoate. The ketonic ester is reduced with lithium aluminum hydride in tetrahydrofuran under nitrogen to yield α1 -[[(1,1-dimethylethyl)-(phenylmethyl)amino]methyl]-4-hydroxy-1,3-benzenedimethanol which is subsequently debenzylated with hydrogen in the presence of palladium on carbon catalyst to produce albuterol.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US05011993 |
| 출처 데이터셋 | uspto-grants-1991_04 |
| ORD ID | ord-5b8dcbadf97f4773909981ee451ff8e5 |
| 출처 메모 | uspto-grants-1991_04 |